Active sacral neuromodulator during pregnancy: a unique case report.
Apostolos Mamopoulos1, Thomas Stavrakis1, Georgios Mavromatidis1
13rd Department of Obstetrics & Gynecology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
American Journal of Obstetrics and Gynecology
|April 16, 2014
Summary
Sacral neuromodulation (SNM) for urinary retention and overactive bladder appears safe during pregnancy. This case study shows a healthy full-term pregnancy and delivery with an implanted SNM device, suggesting it may be preferable to intermittent catheterization.
Area of Science:
- Urology
- Neurology
- Obstetrics
Background:
- Sacral neuromodulation (SNM) is a treatment for refractory urinary retention and overactive bladder.
- The safety of SNM during pregnancy is not well-established.
- Conservative treatments are often insufficient for these conditions.
Observation:
- This report details a 34-year-old pregnant woman with an implanted SNM device.
- The device remained active throughout her pregnancy.
- The patient underwent a cesarean section for delivery.
Findings:
- The pregnancy progressed to full term.
- A healthy infant was delivered.
- No adverse effects related to SNM were observed during pregnancy or delivery.
Implications:
- Sacral neuromodulation may be a safe and viable treatment option for pregnant women with urinary dysfunction.
- SNM during pregnancy could potentially reduce the risk of urinary tract infections associated with intermittent catheterization.
- Further research is warranted to confirm the safety and efficacy of SNM in pregnant populations.
